Responses to Government consultations

Breast Cancer Care responds to Government consultations whenever possible, to make sure the voice of people affected by breast cancer is heard by Parliamentarians and policy makers.

We respond on a wide range of issues that have an impact on the lives of people affected by breast cancer, from prescription charges to embryo screening.

If you would like more information on any of our responses, please contact us.

Prescription charges in Scotland
Click here to download the pdf

Welfare reform green paper
Click here to download the pdf

Embryo screening
Click here to download the pdf

Co-payments in the NHS
Click here to download the pdf

Press Releases

Breast Cancer Care responds to MPs' rejection of House of Loards amendments to the Welfare Reform Bill

Responding to MPs’ rejection of the House of Lords’ amendments to the Welfare Reform Bill in the House of Commons today (Wednesday 1 February 2012), Liz Carroll, Director of Policy and Research at Breast Cancer Care said:

Breast Cancer Care: Valuing Older Women

Breast Cancer Care is publishing recommendations on how to improve outcomes and experiences for older women with breast cancer in a new policy briefing, supported by Age UK.

Breast Cancer Care launches policy briefing: Improving outcomes and experiences for older women with breast cancer

Breast Cancer Care, the leading breast cancer support and information charity in the UK, has produced a new report, backed by Age UK, that makes clear recommendations to improve outcomes and experiences for older women with breast cancer, a demographic proven to have poorer relative survival rates and an increased likelihood of presenting later with symptoms and of receiving non-standard treatments.

Breast Cancer Care: Reaction to NICE recommendation on bevacizumab (Avastin)

Commenting on NICE's recommendation on bevacizumab (Avastin), Dr Emma Pennery, Clinical Director at Breast Cancer Care said.

Breast Cancer Care on research published in the Lancet Oncology online

The results of this large-scale study are very reassuring as they confirm that current NICE guidance1 , which recommends annual mammograms for women over 40 who are at an increased risk of breast cancer, is effective.

More Articles ...

Newsletter sign up

By signing-up you agree to the terms of use and privacy policy.

Unsubscribe